Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, et al. Hum Reprod 2021 Feb 14. pii: 6134861. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, et al. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Hum Reprod 2021 Feb 14. pii: 6134861. doi: 10.1093.
PMID: 33582778